The current price of JAZZ is $227.32 — it has decreased by 3.13% since the previous close. Data as of Nov 5, 2026.
JAZZ is up 8.44% over the past week, down 3.69% over the past month and up 65.66% over the past year. The price is above its 200-day moving average of $217.48.
Analysts' average 12-month price target for JAZZ is $292.27, which implies 28.57% upside from the current price. Individual estimates range from $229.00 to $337.00.
Of the 22 analysts covering Jazz Pharmaceuticals plc, 7 rate it a strong buy, 13 rate it a buy and 2 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Jazz Pharmaceuticals plc has a market capitalization of $14.59B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Jazz Pharmaceuticals plc posted a loss of $3.88 per share against an estimate of -$4.03, beating expectations by 3.72%. Upcoming reports are listed in the earnings calendar.
Jazz Pharmaceuticals plc reported revenue of $1.24B in its most recent quarter, which has increased by 10.38% compared with the same quarter a year earlier. Analysts had expected $1.21B.
Jazz Pharmaceuticals plc has not paid any dividends over the past year.
Companies most comparable to Jazz Pharmaceuticals plc include UCB S.A., Genmab A/S, Incyte Corporation, Neurocrine Biosciences, Inc. and TG Therapeutics, Inc.
In the latest trading session JAZZ moved between $227.05 and $233.80, a range of 2.97% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Jazz Pharmaceuticals plc shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Jazz Pharmaceuticals plc is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks JAZZ has traded between $128.80 and $266.38. The current price is 14.66% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.